Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial

BACKGROUND: Approximately 30% of patients with Crohn disease (CD) are unresponsive to biologics. No previous study has focused on a plant-based diet in an induction phase of CD treatment. OBJECTIVE: To investigate the remission rate of infliximab combined with a plant-based diet as first-line (IPF)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Perm J
Päätekijät: Chiba, Mitsuro, Tsuji, Tsuyotoshi, Nakane, Kunio, Tsuda, Satoko, Ishii, Hajime, Ohno, Hideo, Watanabe, Kenta, Ito, Mai, Komatsu, Masafumi, Sugawara, Takeshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Permanente Journal 2017
Aiheet:
Original Research & Contributions
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5638637/
https://ncbi.nlm.nih.gov/pubmed/29035182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/17-009
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia